U.S. News & World Report features ASA's joint GLP-1 agonist guidance

News of the clinical practice guidance for the safe use of GLP-1 agonists in the perioperative period issued on Oct. 29 by ASA, in collaboration with four other medical societies, has been featured in U.S. News & World Report, MedPage Today, and Becker’s ASC Review, among other outlets. “In many cases, patients with scheduled procedures should continue taking the drug. Scheduling of elective procedures should integrate awareness of circumstances when the risk of delayed stomach emptying is highest, such as when the patient is just beginning the drug and the dose is being increased, as well as for patients with significant GI symptoms,” said ASA President Donald E. Arnold, MD, FASA. “Ideally, these risk factors should be assessed and minimized in advance, so the surgery or procedure can safely proceed.”